Cefaclor
- Generic Name
- Cefaclor
- Drug Type
- Small Molecule
- Chemical Formula
- C15H14ClN3O4S
- CAS Number
- 53994-73-3
- Unique Ingredient Identifier
- 3Z6FS3IK0K
Overview
Semisynthetic, broad-spectrum antibiotic derivative of cephalexin.
Background
Semisynthetic, broad-spectrum antibiotic derivative of cephalexin.
Indication
For the treatment of certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections.
Associated Conditions
- Acute Exacerbation of Chronic Bronchitis caused by Streptococcus Pneumoniae
- Acute Exacerbations of Chronic Bronchitis caused by Haemophilus Influenza
- Acute Exacerbations of Chronic Bronchitis caused by Moraxella catarrhalis
- Bacterial Infections
- Bacterial Urinary Tract Infections
- Lower respiratory tract infection bacterial
- Staphylococcal Skin Infections
- Streptococcal Pharyngitis
- Tonsillitis streptococcal
- Bacterial otitis media
- Streptococcus pyogenes skin infection
- Susceptible Bacterial Infections
Clinical Trials
FDA Approved Products
Cefaclor
Manufacturer:Physicians Total Care, Inc.
Route:ORAL
Strength:250 mg in 1 1
Approved: 2010/12/08
NDC:54868-3478
Cefaclor
Manufacturer:Physicians Total Care, Inc.
Route:ORAL
Strength:500 mg in 1 1
Approved: 2010/12/08
NDC:54868-3511
Cefaclor
Manufacturer:Carlsbad Technology, Inc.
Route:ORAL
Strength:187 mg in 5 mL
Approved: 2015/09/09
NDC:61442-174
Cefaclor
Manufacturer:Carlsbad Technology, Inc.
Route:ORAL
Strength:125 mg in 5 mL
Approved: 2015/09/09
NDC:61442-173
Cefaclor
Manufacturer:Carlsbad Technology, Inc.
Route:ORAL
Strength:375 mg in 5 mL
Approved: 2015/09/09
NDC:61442-176
Singapore Approved Products
CLEANCEF CAPSULE 250 mg
Manufacturer:SHIN POONG PHARMACEUTICAL CO LTD
Form:CAPSULE
Strength:250 mg
Online:Yes
Approved: 1997/04/10
Approval:SIN09294P
SOFICLOR FOR ORAL SUSPENSION 125 mg/5 ml
Manufacturer:XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
Form:GRANULE, FOR SUSPENSION
Strength:125 mg/5 ml
Online:Yes
Approved: 2001/11/27
Approval:SIN11733P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath